TP53 and Merkel cell skin cancer: We assessed sensitivity to IMPDH inhibition in a panel of newly generated MCC patient-derived cell lines (PDCLs) including both MCCP cell lines (MCCP301 and MCCP336) with wildtype TP53 and MCCN cell lines with mutated TP53 (MCCN290 and MCCN350).35